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Abstract
A range of industrial H. polymorpha-based processes exist, most of them for the production of
pharmaceuticals. The established industrial processes lean on the use of promoters derived from
MOX  and  FMD, genes of the methanol metabolism pathway. In Hansenula polymorpha these
promoters are de-repressed upon depletion of a range of carbon sources like glucose and glycerol
instead of being induced by methanol as reported for other methylotrophs. Due to these
characteristics screening and fermentation modes have been defined for strains harbouring such
expression control elements that lean on a limited supplementation of glycerol or glucose to a
culture medium. For fermentation of H. polymorpha a synthetic minimal medium (SYN6) has been
developed. No industrial processes have been developed so far based on Arxula adeninivorans and
only a limited range of strong promoter elements exists, suitable for heterologous gene expression.
SYN6 originally designed for H. polymorpha provided a suitable basis for the initial definition of
fermentation conditions for this dimorphic yeast. Characteristics like osmo- and thermotolerance
can be addressed for the definition of culture conditions.
Hansenula polymorpha and Arxula adeninivorans 
and their competitive environment
In the last three decades a wide range of recombinant pro-
teins, especially pharmaceuticals, have been produced
based on heterologous gene expression in bacterial organ-
isms, mammalian cells and several yeasts and fungi [1-3].
Production processes had to be developed that employ
platforms which meet both, the demand for efficient mass
production and criteria of safety and authenticity of the
produced compounds. In this respect yeasts offer consid-
erable advantages over alternative microbial and mamma-
lian cell systems in providing low-cost screening and
production systems for authentically processed and mod-
ified proteins. The organisms meet safety prerequisites in
that they do not harbour pyrogens, pathogens or viral
inclusions [4,5]. Recent engineering of yeast hosts with
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the capability to add humanized N-glycans of the inter-
mediate mannose type [6] or even the complex type [7]
provides the option to produce biopharmaceuticals with
human protein modifications. The recognition of yeasts
as attractive expression platforms for biopharmaceuticals
is met by genome analysis of an increasing number of
yeast species, among others that of Saccharomyces cerevisiae
[8] and Hansenula polymorpha [9].
As a consequence some early examples of FDA-approved
biopharmaceuticals like insulin [2] and hepatitis B vac-
cines [10,11] have been produced in the baker's yeast S.
cerevisiae. However, certain limitations and drawbacks are
encountered when using this system: S. cerevisiae tends to
hyperglycosylate recombinant proteins; N-linked carbo-
hydrate chains are terminated by mannose attached to the
chain via an α1,3 bond, which is considered to be aller-
genic. The limited carbon source utilization imposes
restrictions on the design of fermentation processes; due
to the preferential use of episomal vectors instabilities of
recombinant strains and as a result batch inconsistencies
of production runs are of major concern [12].
Therefore an increasing number of alternative yeast sys-
tems have been defined that can potentially overcome the
described limitations of the traditional baker's yeast. The
availability of a wide-range yeast vector system (CoMed™)
enables the assessment of several yeasts in parallel for
their capability to produce a particular protein in desired
quality with a single vector to identify an optimal host at
the beginning of a product and process development. For
expression control the wide-range vector contains a con-
stitutive TEF1 promoter derived from various sources that
is active in all yeast species analyzed so far. If needed this
promoter element can easily be substituted during further
strain development by a promoter optimal for the defined
platform [[13], Additional file 1]. Out of the plethora of
addressable species we describe in this article methylo-
trophic H. polymorpha, a recognized producer of biophar-
maceuticals and other recombinant proteins, and
dimorphic Arxula adeninivorans, a novel platform that has
yet to establish itself for industrial applications. First
experiments indicate that screening and fermentation
conditions based on minimal SYN6 medium (SYN6) with
glucose supplementation as described in this article can
also be applied to yeast platforms others than H. polymor-
pha and A. adeninivorans.
H. polymorpha (Pichia angusta) belongs to a limited
number of yeast species that are able to utilize methanol
as a sole energy and carbon source. Two out of three basic
strains with unclear relationships, different features, and
independent origins are biotechnologically applied: strain
CBS4732 (CCY38-22-2, ATCC34438, NRRL-Y-5445) and
DL-1 (NRRL-Y-7560, ATCC26012) and auxotrophic
derivatives thereof [14,15]. A micrograph of a H. polymor-
pha cell prepared from a chemostat with a methanol feed
is shown in Fig. 1a.
The range of biotechnologically applied methylotrophic
yeasts furthermore includes Candida boidinii, Pichia meth-
anolica, and Pichia pastoris [16]. In all instances most
examples of heterologous gene expression are linked to
strong and adjustable promoters derived from genes of
the methanol utilization pathway [12,17], most com-
monly the elements derived from the alcohol oxidase
genes, namely AOX1 from P. pastoris [16-18], MOX from
H. polymorpha [14,17]; AOD1 from C. boidinii [16,17,19]
and AUG1 (now designated MOD1) from P. methanolica
[16,17,20]. In H. polymorpha the FMD (formate dehydro-
genase) promoter, derived from another methanol utiliza-
tion pathway gene of similar regulation, has found
preferential application to established industrial processes
[14,16].
A. adeninivorans (Blastobotrys adeninivorans) is a yeast with
unusual characteristics. It is a dimorphic species and can
utilize adenine, xanthine, uric acid, putrescine and n-
alkylamines as carbon, nitrogen or energy sources in addi-
tion to glucose. Like H. polymorpha it is a nitrate-assimilat-
ing, thermo- and osmotolerant organism. A distinctive
feature is a temperature-dependent dimorphism with
mycelial structures formed at temperatures above 42°C
[5,12] [Fig. 1b, c]. For Fe(II)-oxidase Afet3p, O-glycosyla-
tion was observed to be restricted to the budding cell sta-
tus [21]. It remains to be shown whether this differential
O-glycosylation pattern in correlation to the morphologi-
cal status is also present in recombinant and other host
proteins. Again, several strains have been identified after
its first description as Trichosporon adeninovorans [22].
Most of the research and the biotechnological applica-
tions have been performed with strain LS3 (PAR-4), iso-
lated in Sibiria by Kapultsevich, and a range of
auxotrophic mutants have been generated [5,12]. Strain
135 is a mutant that forms mycelial structures at 30°C
[23]. Recently auxotrophic host strains for heterologous
gene expression have been generated based on strains
CBS7350 and CBS1738 (see Tab. 1). So far, no industrial
A. adeninivorans-based process exists. For expression and
fermentation studies on a laboratory scale heterologous
genes were mostly expressed under control of TEF1, a con-
stitutive A. adeninivorans-derived promoter of appropriate
strength [5].
For description we selected established H. polymorpha-
based processes with strains expressing a heterologous
gene under control of the adjustable FMD and MOX pro-
moters and A. adeninivorans-based lab scale processes with
strains expressing a heterologous gene under control of
the constitutive A. adeninivorans-derived TEF1 promoter,Microbial Cell Factories 2009, 8:22 http://www.microbialcellfactories.com/content/8/1/22
Page 3 of 10
(page number not for citation purposes)
with culturing conditions that can possibly be applied to
the assessment of other yeasts with constitutive heterolo-
gous gene expression. Micrographs of the two selected
platforms are shown in Fig. 1.
H. polymorpha-based processes under control of 
MOX and FMD promoters – a re-assessment
MOX and FMD are genes encoding enzymes of the meth-
anol utilization pathway that is shared by all methylo-
trophic yeasts. The enzyme components of this pathway
and their control have been reviewed extensively in the
recent past [4,17,19]. The genes of this pathway are
described to be tightly regulated; they are highly repressed
in the presence of non-limiting concentrations of glucose
and strongly induced if methanol is used as a carbon
source [17]. Methylotrophic growth is furthermore
accompanied by a massive proliferation of peroxisomes in
which several methanol-metabolizing enzymes are com-
partmentalized [19,24]. However, it soon became evident
that activation of methanol pathway promoters did not
depend on the presence of methanol in H. polymorpha in
contrast to the situation in the other methylotrophs [16].
For all other methylotrophic yeast species an inductive
activation of such promoters has been stated that is strictly
dependent on the presence of methanol [17]. As a conse-
quence several H. polymorpha-based industrial fermenta-
tion processes have been defined that lean on glucose or
glycerol supplementation in suitable concentrations to a
culture broth without any methanol additions [1,25,26].
The distinct feature of the H. polymorpha-derived metha-
nol pathway promoters was elucidated, when new tools of
genomics and postgenomic analysis became available.
After sequencing the entire genome of strain CBS4732 [9]
a cDNA microarray was constructed that allowed compre-
hensive gene expression profiling [27,28]. When analyz-
ing the transcriptome of H. polymorpha strains of glucose-
supplemented growth and after transition to methanol-
supplemented growth it became evident that the metha-
nol dissimilation genes including MOX and FMD are acti-
vated by de-repression upon carbon source limitation and
depletion and not upon induction by methanol. In con-
trast genes of peroxisome biogenesis and proliferation are
induced by methanol [14,15].
With respect to these findings, recombinant H. polymorpha
strains expressing a GFP reporter gene under control of the
FMD promoter were screened applying glucose- or glyc-
erol-supplemented media to strain culturing.
High throughput screening experiments are usually per-
formed in a batch-mode [29]. Jeude et al. described a sys-
tem for the slow release of glucose from a silicone
elastomere matrix in shake flask [30]. They showed the
advantage of using fed-batch cultivations in contrast to
Microscopy analysis of Hansenula polymorpha and Arxula aden- inivorans cells Figure 1
Microscopy analysis of Hansenula polymorpha and 
Arxula adeninivorans cells. a H. polymorpha cell grown in a 
methanol-supplemented chemostat (courtesy by M. Veen-
huis, Groningen). Under these growth conditions prolifera-
tion of peroxisomes is induced. b A. adeninivorans cells grown 
at 37°C. c A. adeninivorans cells grown at 42°C. Dimorphic A. 
adeninivorans grows in filamentous forms above 42°C.
a
b 
cMicrobial Cell Factories 2009, 8:22 http://www.microbialcellfactories.com/content/8/1/22
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batch cultivations in small scale, where up to 420-fold
increased GFP production was reached [30]. The slow-
release technique was transferred to a deep-well-plate for-
mat. In these plates the glucose-containing silicone matrix
is fixed at the bottom of each well. Hence, 96 parallel fed-
batch-cultivations can be performed. A comparative
screening with different H. polymorpha pC10-FMD (PFMD-
GFP) strains (strains of a CBS4732 background) [31] was
performed in batch mode with glycerol and glucose sup-
plementation and in fed-batch mode with glucose supple-
mentation [Fig. 2a]. The comparison attests that clones
with an FMD promoter-controlled gene expression can be
screened in small volumes of media supplemented with
glycerol or glucose. This supports that methanol pathway
promoters are activated upon glycerol and glucose deple-
tion as suggested by the transcriptome analysis. Interest-
ingly some clones of maximal productivity identified
under conditions of glucose starvation (fed-batch condi-
tions) are not identical to those identified under condi-
tion of glycerol starvation (batch conditions). The reasons
for this phenomenon remain obscure. MOX promoter-
driven GFP expression under glucose starvation condi-
tions was corroborated for recombinant strains of a DL-1
background cultured in a different medium and on a
larger scale as shown by fluorescence analysis in Fig. 2b.
The commercial success of a recombinant product does
not depend only on the characteristics of the microbial
host but also to a large extent on the definition of efficient
fermentation processes. In case of H. polymorpha, a
defined minimal mineral medium has been developed
designated SYN6 [25,32]. It is composed of salts, vitamins
and trace elements to support growth to high cell densities
and it has to be adjusted to appropriate pH conditions
and has to be supplemented with suitable carbon sources
(for details of components see [32]). The fermentation
strategy in previous established process developments
with FMD or MOX promoter-driven production relied on
growth using either glucose or glycerol in the beginning of
fermentation, followed by carbon source limitations in a
second phase. The respective fermentation parameters for
the supplementation of glucose or glycerol have been
defined prior to the elucidation of the transcriptome pro-
file described before. In a single process example the fer-
mentation broth was supplemented in a late phase with
methanol. The three different fermentation modes are
schematically depicted in Fig. 3a–c.
An early example for a glycerol starvation process is the
production process for hirudin [33-35] [Fig. 3a]. As in all
other described processes expression vectors were con-
structed to transform the uracil-auxotrophic strain RB11,
like strain MedHp1 (Tab. 1) a derivative of strain LR9 [36-
38]. The vectors contain an expression cassette with a
hirudin sequence under control of the MOX promoter.
For secretion it was fused to a secretion leader, derived
from the pheromone precursor MFα1p [33]. Fermenta-
tion on a 35 liter scale was carried out at 30°C in SYN6 at
pH 5. It was started with 30 g/L of glycerol. After con-
sumption of the carbon source after 35 hours a feed was
initiated that added glycerol by a pO2-controlled feeding
device. Hirudin production started after some 20 hours
when the MOX-promoter was activated by de-repression
under glycerol limitation. The subsequent feeding condi-
tions supported the de-repressed status of the promoter by
maintaining glycerol concentrations between 0.5 and 3.0
g/L. These feeding conditions resulted in an increasing
accumulation of the product in the medium [33,34,39]
[Fig. 3a].
Similar fermentation conditions were applied to culturing
of production strains for the anticoagulant saratin [35,39]
or for aprotinin [37], now applying the FMD promoter to
expression control. This fermentation design was modi-
fied when developing a production process for the
cytokine IFNalpha-2a [40,41]. IFNalpha-2a forms a
disulfide bond between amino acids Cys1 and Cys98.
Bond formation of the first amino acid Cys1 of the mature
sequence provides a steric hindrance for correct matura-
tion when processed from an MFα1/IFNalpha-2a precur-
sor. Accordingly a large share of secreted recombinant
hirudin consisted of incorrectly processed molecules with
N-terminal extensions. This could be overcome by co-pro-
duction of the processing enzyme Kex2p, however at the
expense of a more pronounced proteolytic degradation.
To minimize this degradation pH was lowered from pH 5
(as applied to standard fermentations) to pH 2–3. The
glycerol starvation conditions for FMD  promoter de-
repression remained unchanged.
For the production of phytase an extremely efficient pro-
duction process has been developed. In this process all
steps and components of the process followed a rationale
of efficiency and cost-effectiveness. This rationale pro-
voked an assessment of glucose as sole carbon source for
fermentation [42]. In a fermentation of a phytase produc-
tion strain with FMD-controlled expression on 2000 L
scale glucose was supplemented as 20 g/L. Upon deple-
tion, a glucose-limiting feed was initiated that added the
carbon source with a stepwise increasing feeding rate in
correlation to the cell mass. In this glucose starvation
process a final yield of 13.5 g/L phytase was observed
[42,43] [Fig. 3b].
The only established industrial fermentation process with
methanol supplementation is that for the production of
the hepatitis B surface antigen HBsAg, the first biophar-
maceutical produced in H. polymorpha. Several processes
for this vaccine have been described that are based on
both, MOX or FMD-controlled expression [11]. In Fig. 3cMicrobial Cell Factories 2009, 8:22 http://www.microbialcellfactories.com/content/8/1/22
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a typical fermentation process is schematically shown.
The batch phase and a first fed-batch phase is similar to
the examples of glycerol starvation described before [Fig.
3a]. In contrast a mixture of glycerol and methanol is fed
during the last hours of fermentation. Obviously this
results in an inductive increase of HBsAg production.
However, in view of the transcriptome profiling it seems
that methanol supplementation does not induce the
FMD-controlled expression of the heterologous antigen
gene, but it induces membrane proliferation. As the
HBsAg is produced as particles with the recombinant anti-
gen inserted into host-derived membranes, methanol is
considered to provide a balanced co-production of both
particle components in high titers [10,11].
The selected process examples demonstrate the possibility
to develop efficient screening and fermentation processes
for strains with MOX- or FMD-driven heterologous gene
expression without methanol supplementation to a
medium.
Culturing of Arxula adeninivorans strains
For A. adeninivorans industrial process parameters have
not been defined yet and mainly cultivations on a shake
flask scale have been carried out so far. Most of the current
expression studies are based on wild type strain LS3 [44]
or its leucine-auxotrophic derivative G1211. Additional
strains and leucine-auxotrophic mutants thereof have
been established more recently (see Tab. 1).
Acid phosphatase production was characterized in fer-
mentations of both strain LS3 and a recombinant strain
expressing the APHO1 gene under control of the strong
TEF1 promoter [45]. Using the Plackett-Burman design
three variables (pH, sucrose concentrations, and peptone
concentration) were optimized for medium composition,
a roughly four times enhancement was observed in media
containing 39 g/L sucrose and 16 g/L peptone at pH 3.8
[46].
Shake flask cultures of A. adeninivorans strains were ana-
lyzed using a device for online measurement of the respi-
ration rates (RAMOS, respiratory activity monitoring
system) [47,48]. This device had previously been applied
to the analysis of H. polymorpha cultures and to alternative
platforms [49-52].
In a first series yeast minimal medium (YMM) was
assessed. Prior to any practical experiment, YMM ammo-
nium concentration of the standard medium was raised
from 2.2 mmol N/g glucose to 4.6 mmol N/g glucose
since theoretical material balancing revealed a severe lack
of nitrogen with regard to the average nitrogen content of
yeast. The culture broth was additionally supplemented
with calcium and iron in higher concentrations as well as
Methanol pathway promoter-controlled GFP production in  recombinant H. polymorpha strains Figure 2
Methanol pathway promoter-controlled GFP production 
in recombinant H. polymorpha strains. A. Screening of 
CBS4732-derived transformants producing GFP under control of 
the FMD promoter. Screening of 44 different H. polymorpha 
pC10-FMD (PFMD-GFP) clones cultured under different cultivation 
modes; screening experiments were performed in deep-well-
plates for batch and in FeedBead96-plates for fed-batch cultiva-
tion. Gas permeable sealings were used as sterile closures. To 
reduce the evaporation during the cultivation, water-saturated air 
was used for gassing. To compare the results from the different 
cultivation modes an identical carbon source concentration of 
16.63 g/L were applied to each fermentation (batch with glycerol, 
batch with glucose, fed-batch with glucose). The batch cultivations 
were stopped when the stationary growth phase (glycerol 21 h, 
glucose 16 h) was reached and the fed-batch cultivations were 
stopped when 16.63 g/L glucose were released from the 
FeadBeat96-plate (16 h). Dry cell weight (DCW) was calculated 
from optical density measurements in a PowerWave ×340 micro 
titer plate reader. Green Fluorescent Protein (GFP) was meas-
ured at 485 nm excitation and 520 nm emission wavelengths. Cul-
tivation conditions: shaking frequency 400 rpm, shaking diameter 
50 mm, temperature 37°C, filling volumes 300 μL per well; media: 
SYN6-MES with 16.63 g/L of different carbon sources. Carbon 
sources: batch mode with glycerol (black line), batch mode with 
glucose (grey bars), fed-batch mode with glucose (black bars); 
inocula ratio 1:30. B. GFP production in a DL-1-derived trans-
formant under control of the MOX promoter. H. polymorpha 
transformants producing GFP under control of MOX promoter 
were cultured for 12 h on YP medium containing 10 g/L methanol 
(YP+1%M) or 0.5 g/L glucose (YP+0.05%D) and then analyzed by 
confocal microscopy.
a
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A, B, C: Schematic depiction of H. polymorpha-based fermentation processes Figure 3
A, B, C: Schematic depiction of H. polymorpha-based fermentation processes. The figures are modified versions of 
figures from previous publications. For further details see text. a fermentation of a hirudin-producing strain (MOX promoter-
controlled expression, glycerol starvation), b fermentation of a phytase-producing strain (FMD promoter-controlled gene 
expression, glucose starvation), c fermentation of a HBsAg-producing strain (FMD promoter-controlled expression, glycerol 
starvation, followed by a glycerol/methanol feed). dotted line: dry cell weight, solid line: glycerol (a, c) or glucose (b), chain dot-
ted line: glucose feeding rate (b) or methanol (c), dashed line: product of a, b and c respectively.
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with MES (2-[N-morpholino]ethanesulfonic acid) for
buffering to result in YMM* [25]. Despite nitrogen addi-
tion to YMM, the respective cultures remained limited as
shown representatively for A. adeninivorans LS3 in Fig. 4,
black circles. Initially, culture respiration increased expo-
nentially, but was then limited to 9 mmol/(L*h) after 13
hours, and continued to decline over fermentation time.
Finally only ca. 6.6 g dry cell weight (DCW)/L was
obtained.
In fermentations of strain LS3 in MES-buffered YMM* the
respiration rate exponentially increased followed by a lin-
ear increase presumably indicating a nutrient deficiency.
After 24 hours, respiration rate dropped upon glucose
depletion. [Fig. 4, grey circles].
Subsequently glucose-supplemented SYN6 was assessed
for applicability to shake flask cultures of A. adeninivorans.
The high nutrient concentrations of standard SYN6
remained unchanged. Again, the pH of SYN6 had to be
buffered with MES (SYN6-MES, see [25] for detailed
description) for pH stabilization between 6.4 and 5.3. Fig.
4, open circles shows the respiration rate of a shake flask
culture with strain LS3 in SYN6-MES. The described cul-
ture course adverts to the non-limited growth of A. aden-
inivorans  in the respective shake flask culture. Thus,
favourable non-limiting growth conditions for A. adenini-
vorans in shake flasks were proven to be developed.
Additionally suitable fed-batch conditions for high cell
density fermentations (HCDF) in SYN6 were found. These
conditions were assessed for culturing a recombinant A.
adeninivorans strain producing phytase under control of
the TEF1 promoter [5,53]. During the feeding under glu-
cose-limitation phytase was secreted to maximal titres of
ca. 900 FTU/mL (one FTU equates to the phytase amount
liberating 1 μmol of inorganic phosphate per minute at
pH 5.5 and 37°C) [25]. Thus, the growth conditions
defined for shake flask cultures and HCDF of A. adeninivo-
rans wild type strain LS3, proved to be applicable for the
phytase-producing recombinant A. adeninivorans strain.
Finally the phytase-producing strain was cultured under
pressurized conditions in a 50 L STR, again using a SYN6-
derived medium for culturing. During the fed-batch phase
the reactor pressure was increased stepwise up to 5 bar.
After 42 h cells had grown up to 224 g/L. Phytase amount
CoMed™ vector system Figure 5
CoMed™ vector system. The basic vectors are derived 
from standard vectors with an engineered multiple cloning 
site (MCS) for the uptake of various modules. In its basic 
form all modules are functional in all yeasts tested so far. 
Module 1: ARS/CEN sequences from various sources 
(optional); Module 2: rDNA targeting sequences (NTS2-ETS-
18SrDNA-ITS1 from various sources); Module 3: selection 
markers (i.e. kanMX, hph, leu2, ura3 and combinations 
thereof); Module 4: expression cassettes consisting of a TEF1 
promoter from various sources – cloning site – terminator. 
The wide-range TEF1 promoter can easily be replaced by 
alternative strong species-specific promoters like MOX or 
FMD. For further details see text.
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Module 4
Eco47III
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NotI
BcuI
(SphI)
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(BsiWI)
ApaI
Amp(r)
pCoMedTM
basic vector
II.
ColE1 ori
I.
f1(-) origin
Assessment of minimal media for Arxula adeninivorans LS3 by  measuring respiration rates in shake flask cultures (for oper- ating conditions and media formulation see [25]) Figure 4
Assessment of minimal media for Arxula adeninivo-
rans LS3 by measuring respiration rates in shake flask 
cultures (for operating conditions and media formu-
lation see [25]). Original YMM (black circles), containing 
poor concentrations of calcium (0.338 mg/L) and iron (0.041 
mg/L), led to poor culture respiration rates below 10 mmol/
(L*h). Modified YMM* (grey circles) is pH-buffered with MES 
and contains higher concentrations of calcium (272.8 mg/L) 
and iron (2.1 mg/L), thus leading to a more vital cultivation as 
shown by the higher respiration rate of up to 25 mmol/(L*h) 
and a condensed cultivation time of 24 hours (see drop of 
respiration, signalling the depletion of the carbon source glu-
cose). SYN6-MES (open circles), containing exceeding nutri-
ent quantities, provided non-limited growth of the culture as 
shown by the distinct exponential increase of respiration to 
45 mmol/(L*h) and an early cease of respiration after only 15 
hours, again signalling the depletion of carbon source.
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increased up to 10 × 106 FTU. Fermentations under pres-
surized conditions may result in increased product yields
and shorter fermentation time [54].
The conditions of culturing can potentially be applied to
screening and culturing of other yeasts expressing a for-
eign gene under control of a constitutive TEF1 promoter –
a key element of the CoMed™ system described in the fol-
lowing section.
The CoMed™ system
While all established expression systems are distinguished
by certain favorable characteristics, it is evident that no
single system is optimal for all proteins. An initial selec-
tion can result in costly time- and resource-consuming
failures. It is thus advisable to assess several platform can-
didates in parallel for criteria such as productivity, appro-
priate processing and modification. Production of
interleukin IL-6 in various yeast platforms has recently
been described as a striking example for the necessity of a
comparative evaluation of several yeasts. Correct process-
ing from an MFα1/IL-6 precursor was observed in A. aden-
inivorans whereas N-terminally truncated molecules were
secreted from S. cerevisiae and H. polymorpha hosts [55]. A
novel yeast/vector system provides a versatile tool to
address simultaneously with a single vector a range of
yeasts like the two described before, namely Hansenula
polymorpha and Arxula adeninivorans, and others like Sac-
charomyces cerevisiae, Pichia pastoris, Kluyveromyces lactis. In
its basic form the vector is composed of genetic modules
that are functional in all yeasts, namely an rDNA targeting
sequence, an appropriate selection marker and an expres-
sion cassette under control of a TEF1 promoter from vari-
ous sources. The CoMed™ system has recently been
described and some application examples have been pro-
vided [13,55-57]. The basic design of the vector and a
selection of addressable yeast species are shown in Fig. 5
and Additional file 1.
It is desirable that the range of yeasts addressed in parallel
can be also assessed in parallel for optimal performance in
a given case. First experiments indicate that SYN6 and
derivatives thereof are suitable minimal media for yeasts
others than A. adeninivorans and H. polymorpha. The gen-
eral use of the constitutive TEF1 promoter is expected to
ensure screening and fermentation conditions similar to
those described for H. polymorpha and A. adeninivorans.
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